MARKET

SGHT

SGHT

Sight Sciences, Inc.
NASDAQ
5.87
+0.18
+3.16%
After Hours: 5.87 0 0.00% 17:43 02/06 EST
OPEN
5.83
PREV CLOSE
5.69
HIGH
5.99
LOW
5.60
VOLUME
152.59K
TURNOVER
--
52 WEEK HIGH
9.24
52 WEEK LOW
2.030
MARKET CAP
310.36M
P/E (TTM)
-6.5543
1D
5D
1M
3M
1Y
5Y
1D
Sight Sciences Extends Menlo Park Headquarters Lease Agreement
TipRanks · 3d ago
Weekly Report: what happened at SGHT last week (0126-0130)?
Weekly Report · 4d ago
SIGHT SCIENCES INC <SGHT.O>: WILLIAM BLAIR RESUMES COVERAGE WITH OUTPERFORM RATING
Reuters · 01/30 13:02
Sight Sciences resumed with an Outperform at William Blair
TipRanks · 01/30 12:21
Weekly Report: what happened at SGHT last week (0119-0123)?
Weekly Report · 01/26 10:35
Top Brass at Sight Sciences Quietly Cashes In With Major Stock Disposals
TipRanks · 01/22 02:01
Sight Sciences CTO David Badawi Reports Disposal of Common Shares
Reuters · 01/21 21:57
Sight Sciences CFO James Rodberg Reports Disposal of Common Shares
Reuters · 01/21 21:56
More
About SGHT
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.

Webull offers Sight Sciences Inc stock information, including NASDAQ: SGHT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGHT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGHT stock methods without spending real money on the virtual paper trading platform.